Sephience PTC THERAPEUTICS AUSTRALIA PTY LIMITED
Product name
Sephience
Accepted date
Jul-2024
Proposed indication
For the treatment of hyperphenylalaninaemia.
Application type
A (new medicine)
Publication date
Jul-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.